Response to letter regarding article, "postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 registry".

@article{Belle2015ResponseTL,
  title={Response to letter regarding article, "postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 registry".},
  author={{\'E}ric Van Belle and Françis Juthier and Sophie Susen and Andr{\'e} Vincentelli and Bernard Iung and Jean Dallongeville and H{\'e}l{\`e}ne Eltchaninoff and Marc Laskar and Pascal N Leprince and Michel Li{\`e}vre and Carlo Banfi and Jean-Luc Auffray and C{\'e}dric Delhaye and Patrick Donzeau-Gouge and Karine Chevreul and Jean Fajadet and Alain Leguerrier and Alain Prat and Martine Gilard and Emmanuel Teiger},
  journal={Circulation},
  year={2015},
  volume={131 2},
  pages={
          e16-7
        }
}
T ranscatheter aortic valve replacement (TAVR) is a technique to treat patients with symptomatic aortic steno-sis and contraindications or at high risk for conventional surgical valve replacement. 1 Two revalving devices based on different technical concepts, self-expandable (SE) or balloon-expandable (BE), have been developed and are currently available. Background—Significant postprocedural aortic regurgitation (AR) is observed in 10% to 20% of cases after transcatheter aortic valve… CONTINUE READING
Highly Cited
This paper has 30 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 18 citations